We are live on
!
Find out more
FAM
Fred Alger Management Portfolio holdings
AUM
$22.8B
1-Year Est. Return
64.63%
This Fund
S&P 500
This Quarter
Est. Return
-7.7%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$31.3B
AUM Growth
-$8.62B
(-22%)
Cap. Flow
-$3.66B
Cap. Flow
% of AUM
-11.69%
Top 10 Holdings %
Top 10 Hldgs %
30.33%
Holding
574
New
67
Increased
165
Reduced
236
Closed
83
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$255M |
| 2 |
Visa
V
|
+$248M |
| 3 |
Intuit
INTU
|
+$235M |
| 4 |
Alibaba
BABA
|
+$229M |
| 5 |
Advanced Micro Devices
AMD
|
+$163M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$381M |
| 2 |
Adobe
ADBE
|
+$304M |
| 3 |
Applied Materials
AMAT
|
+$250M |
| 4 |
Amazon
AMZN
|
+$207M |
| 5 |
Micron Technology
MU
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.83% |
| 2 | Healthcare | 18.53% |
| 3 | Consumer Discretionary | 14.86% |
| 4 | Industrials | 11.27% |
| 5 | Financials | 6.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Novartis
NVS
$297B
| $1.17M | ﹤0.01% |
13,343
+842
| +7% | +$72.9K |
|
377
Cytek Biosciences
CTKB
$545M
| $1.17M | ﹤0.01% |
108,514
-574
| -0.5% | -$7.75K |
|
378
Equinix
EQIX
$101B
| $1.16M | ﹤0.01% |
1,568
-26,432
| -94% | -$19M |
|
379
Fulcrum Therapeutics
FULC
$239M
| $1.16M | ﹤0.01% |
+48,921
| New | +$692K |
|
380
CBRE Group
CBRE
$42.5B
| $1.15M | ﹤0.01% |
12,606
+12,372
| +5,287% | +$1.21M |
|
381
Target
TGT
$65.6B
| $1.12M | ﹤0.01% |
5,267
-81
| -2% | -$17.5K |
|
382
JD.com
JD
$44.6B
| $1.06M | ﹤0.01% |
18,351
+2,900
| +19% | +$197K |
|
383
Flex
FLEX
$41.7B
| $1.05M | ﹤0.01% |
75,380
| – | – |
|
384
MSCI
MSCI
$41.6B
| $1.03M | ﹤0.01% |
2,059
-40
| -2% | -$20.7K |
|
|
TPTX
385
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $1.03M | ﹤0.01% |
38,426
-189
| -0.5% | -$6.35K |
|
386
Dow Inc
DOW
$21.9B
| $1.02M | ﹤0.01% |
16,008
+2,703
| +20% | +$163K |
|
387
Wayfair
W
$11.2B
| $986K | ﹤0.01% |
8,900
+2,192
| +33% | +$309K |
|
|
EAR
388
DELISTED
Eargo, Inc. Common Stock
EAR
| $967K | ﹤0.01% |
9,137
| – | – |
|
389
Newmont
NEM
$98.7B
| $932K | ﹤0.01% |
11,734
+979
| +9% | +$66.2K |
|
390
Cigna
CI
$73.8B
| $931K | ﹤0.01% |
3,885
| – | – |
|
391
Gilead Sciences
GILD
$162B
| $930K | ﹤0.01% |
15,647
+1,325
| +9% | +$84.7K |
|
392
Zoetis
ZTS
$32.4B
| $927K | ﹤0.01% |
4,914
-36,427
| -88% | -$7.2M |
|
393
Accenture
ACN
$102B
| $902K | ﹤0.01% |
2,676
+132
| +5% | +$44.5K |
|
394
Haemonetics
HAE
$3.89B
| $882K | ﹤0.01% |
+13,956
| New | +$759K |
|
395
EyePoint Inc
EYPT
$1.03B
| $876K | ﹤0.01% |
72,100
-110,430
| -60% | -$1.21M |
|
396
Ball Corp
BALL
$17.3B
| $874K | ﹤0.01% |
9,706
| – | – |
|
397
Humana
HUM
$43.7B
| $868K | ﹤0.01% |
1,995
| – | – |
|
398
Alpha Teknova
TKNO
$268M
| $860K | ﹤0.01% |
62,271
-326
| -0.5% | -$5.13K |
|
399
Rapid Micro Biosystems
RPID
$106M
| $858K | ﹤0.01% |
126,323
-713
| -0.6% | -$5.25K |
|
|
GTM
400
ZoomInfo Technologies
GTM
$973M
| $842K | ﹤0.01% |
14,097
-1,341
| -9% | -$72K |
|
Similar funds
CAM
BA
AM
SAM
CHP
Fred Alger Management's Q1 2022 Portfolio in Review
As of Q1 2022, Fred Alger Management held 574 positions worth $31.3B, down 22% from $39.9B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Fred Alger Management withdrew a net $3.66B in Q1 2022, closing 83 positions and reducing 236 holdings. Its most notable exit was Coinbase, an estimated $173M position sold in full.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 38% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Fred Alger Management opened a new position in Alibaba worth $216M.
- Fred Alger Management's largest Q1 2022 buy was Alibaba: 1,989,523 shares worth $216M.
- Fred Alger Management added most to Pioneer Natural Resource Co. in Q1 2022, an estimated $255M increase.
- Fred Alger Management's biggest Q1 2022 reduction was Qualcomm, cutting an estimated $381M.
- Fred Alger Management fully exited Coinbase in Q1 2022, selling an estimated $173M.
- Fred Alger Management's ten largest holdings make up 30% of its $31.3B portfolio in Q1 2022.
- Fred Alger Management opened 67 new positions and closed 83 in Q1 2022.
- Fred Alger Management's portfolio value fell 22% quarter-over-quarter to $31.3B.
Based on Fred Alger Management's 13F filing for Q1 2022, filed 16 May 2022.